Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Karger
International Association for Biologicals (IABS)
2010
|
| Schriftenreihe: | Developments in biologicals
133 |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | XII, 104 S. graph. Darst. |
| ISBN: | 9783805596824 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV037326063 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 110407s2010 sz d||| |||| 10||| eng d | ||
| 010 | |a 2010049427 | ||
| 020 | |a 9783805596824 |9 978-3-8055-9682-4 | ||
| 035 | |a (OCoLC)723332534 | ||
| 035 | |a (DE-599)BVBBV037326063 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a sz |c CH | ||
| 049 | |a DE-12 | ||
| 050 | 0 | |a RS380 | |
| 082 | 0 | |a 615/.19 | |
| 111 | 2 | |a Viral Clearance Symposium |d 2009 |c Indianapolis, Ind. |j Verfasser |0 (DE-588)16107460-1 |4 aut | |
| 245 | 1 | 0 | |a Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 |c eds.: George Miesegaes ... |
| 264 | 1 | |a Karger |b International Association for Biologicals (IABS) |c 2010 | |
| 300 | |a XII, 104 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Developments in biologicals |v 133 | |
| 500 | |a Includes bibliographical references | ||
| 650 | 4 | |a Pharmaceutical biotechnology |v Congresses | |
| 650 | 4 | |a Viral contamination |v Congresses | |
| 650 | 4 | |a Drug Contamination |x prevention & control |v Congresses | |
| 650 | 4 | |a Viruses |v Congresses | |
| 650 | 4 | |a Drug Industry |x methods |v Congresses | |
| 650 | 0 | 7 | |a Biotechnologie |0 (DE-588)4069491-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Viren |0 (DE-588)4063589-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kontamination |0 (DE-588)4032272-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2009 |z Indianapolis Ind. |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 0 | 1 | |a Biotechnologie |0 (DE-588)4069491-4 |D s |
| 689 | 0 | 2 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 3 | |a Kontamination |0 (DE-588)4032272-5 |D s |
| 689 | 0 | 4 | |a Viren |0 (DE-588)4063589-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Miesegaes, George |e Sonstige |4 oth | |
| 830 | 0 | |a Developments in biologicals |v 133 |w (DE-604)BV013104325 |9 133 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-022480124 | ||
Datensatz im Suchindex
| _version_ | 1804145606896123904 |
|---|---|
| any_adam_object | |
| author_corporate | Viral Clearance Symposium Indianapolis, Ind |
| author_corporate_role | aut |
| author_facet | Viral Clearance Symposium Indianapolis, Ind |
| author_sort | Viral Clearance Symposium Indianapolis, Ind |
| building | Verbundindex |
| bvnumber | BV037326063 |
| callnumber-first | R - Medicine |
| callnumber-label | RS380 |
| callnumber-raw | RS380 |
| callnumber-search | RS380 |
| callnumber-sort | RS 3380 |
| callnumber-subject | RS - Pharmacy |
| ctrlnum | (OCoLC)723332534 (DE-599)BVBBV037326063 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02155nam a2200553zcb4500</leader><controlfield tag="001">BV037326063</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110407s2010 sz d||| |||| 10||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2010049427</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783805596824</subfield><subfield code="9">978-3-8055-9682-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)723332534</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV037326063</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">sz</subfield><subfield code="c">CH</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS380</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Viral Clearance Symposium</subfield><subfield code="d">2009</subfield><subfield code="c">Indianapolis, Ind.</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)16107460-1</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009</subfield><subfield code="c">eds.: George Miesegaes ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Karger</subfield><subfield code="b">International Association for Biologicals (IABS)</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 104 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biologicals</subfield><subfield code="v">133</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viral contamination</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Contamination</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viruses</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">methods</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Viren</subfield><subfield code="0">(DE-588)4063589-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontamination</subfield><subfield code="0">(DE-588)4032272-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2009</subfield><subfield code="z">Indianapolis Ind.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Kontamination</subfield><subfield code="0">(DE-588)4032272-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Viren</subfield><subfield code="0">(DE-588)4063589-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miesegaes, George</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biologicals</subfield><subfield code="v">133</subfield><subfield code="w">(DE-604)BV013104325</subfield><subfield code="9">133</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022480124</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2009 Indianapolis Ind. gnd-content |
| genre_facet | Konferenzschrift 2009 Indianapolis Ind. |
| id | DE-604.BV037326063 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T23:22:08Z |
| institution | BVB |
| institution_GND | (DE-588)16107460-1 |
| isbn | 9783805596824 |
| language | English |
| lccn | 2010049427 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022480124 |
| oclc_num | 723332534 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XII, 104 S. graph. Darst. |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | International Association for Biologicals (IABS) |
| record_format | marc |
| series | Developments in biologicals |
| series2 | Developments in biologicals |
| spelling | Viral Clearance Symposium 2009 Indianapolis, Ind. Verfasser (DE-588)16107460-1 aut Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 eds.: George Miesegaes ... Karger International Association for Biologicals (IABS) 2010 XII, 104 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Developments in biologicals 133 Includes bibliographical references Pharmaceutical biotechnology Congresses Viral contamination Congresses Drug Contamination prevention & control Congresses Viruses Congresses Drug Industry methods Congresses Biotechnologie (DE-588)4069491-4 gnd rswk-swf Viren (DE-588)4063589-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Kontamination (DE-588)4032272-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2009 Indianapolis Ind. gnd-content Pharmazeutische Technologie (DE-588)4045699-7 s Biotechnologie (DE-588)4069491-4 s Arzneimittel (DE-588)4003115-9 s Kontamination (DE-588)4032272-5 s Viren (DE-588)4063589-2 s DE-604 Miesegaes, George Sonstige oth Developments in biologicals 133 (DE-604)BV013104325 133 |
| spellingShingle | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 Developments in biologicals Pharmaceutical biotechnology Congresses Viral contamination Congresses Drug Contamination prevention & control Congresses Viruses Congresses Drug Industry methods Congresses Biotechnologie (DE-588)4069491-4 gnd Viren (DE-588)4063589-2 gnd Arzneimittel (DE-588)4003115-9 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Kontamination (DE-588)4032272-5 gnd |
| subject_GND | (DE-588)4069491-4 (DE-588)4063589-2 (DE-588)4003115-9 (DE-588)4045699-7 (DE-588)4032272-5 (DE-588)1071861417 |
| title | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 |
| title_auth | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 |
| title_exact_search | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 |
| title_full | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 eds.: George Miesegaes ... |
| title_fullStr | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 eds.: George Miesegaes ... |
| title_full_unstemmed | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 eds.: George Miesegaes ... |
| title_short | Proceedings of the 2009 Viral Clearance Symposium, Indianapolis, IN, USA, 20-21 March 2009 |
| title_sort | proceedings of the 2009 viral clearance symposium indianapolis in usa 20 21 march 2009 |
| topic | Pharmaceutical biotechnology Congresses Viral contamination Congresses Drug Contamination prevention & control Congresses Viruses Congresses Drug Industry methods Congresses Biotechnologie (DE-588)4069491-4 gnd Viren (DE-588)4063589-2 gnd Arzneimittel (DE-588)4003115-9 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Kontamination (DE-588)4032272-5 gnd |
| topic_facet | Pharmaceutical biotechnology Congresses Viral contamination Congresses Drug Contamination prevention & control Congresses Viruses Congresses Drug Industry methods Congresses Biotechnologie Viren Arzneimittel Pharmazeutische Technologie Kontamination Konferenzschrift 2009 Indianapolis Ind. |
| volume_link | (DE-604)BV013104325 |
| work_keys_str_mv | AT viralclearancesymposiumindianapolisind proceedingsofthe2009viralclearancesymposiumindianapolisinusa2021march2009 AT miesegaesgeorge proceedingsofthe2009viralclearancesymposiumindianapolisinusa2021march2009 |